Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
FDA/EMA/Drug Designation
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
FDA/EMA/Drug Designation
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
FDA/EMA/Drug Designation
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Acquisitions
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
FDA/EMA/Drug Designation
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
FDA/EMA/Drug Designation
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
FDA/EMA/Drug Designation
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
FDA/EMA/Drug Designation
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
FDA/EMA/Drug Designation
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
FDA/EMA/Drug Designation
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
FDA/EMA/Drug Designation
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
FDA/EMA/Drug Designation
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
FDA/EMA/Drug Designation
Frequency Therapeutics Announces $42 Million Private Placement – FirstWord Pharma
FDA/EMA/Drug Designation
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord Pharma
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
FDA/EMA/Drug Designation
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus – FirstWord Pharma
FDA/EMA/Drug Designation
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)...
Firstwordpharma News
-
July 18, 2020
0
FDA/EMA/Drug Designation
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in...
Firstwordpharma News
-
July 18, 2020
0
FDA/EMA/Drug Designation
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement...
Firstwordpharma News
-
July 18, 2020
0
FDA/EMA/Drug Designation
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Firstwordpharma News
-
July 18, 2020
0
FDA/EMA/Drug Designation
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
July 18, 2020
0
1
2
3
...
108
Page 1 of 108
- Advertisement -
MOST POPULAR
Sunovion Announces Appointment of Dr. Antony Loebel as President and CEO,...
March 4, 2019
AVROBIO Announces Clinical Data Presentation and Multiple Events at WORLDSymposium 2020
February 4, 2020
Scottish Medicines Consortium latanoprost + timolol (Fixapost)
May 13, 2019
CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and...
July 18, 2019
Load more
HOT NEWS
Commercial
ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference...
Commercial
Karuna Completes $80 Million Series B Financing
Others
Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and...
Others
Bill Supporting U.S. Pharma Manufacturing Introduced to Senate
